Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health SystemScott Dryden‐Peterson, Ann E. Woolley, Lindsay Gainer et al.|Annals of Internal Medicine|2022Cited by 186
Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health systemScott Dryden‐Peterson, Ann E. Woolley, Andy Kim et al.|medRxiv|2022Cited by 42
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After VaccinationCrystal M. North, Chana A. Sacks, Amy K. Barczak et al.|Clinical Infectious Diseases|2021Cited by 33